A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2004
11/24/2004	CN1176658C Aseptic freeze-dried prostaglandin injection and its preparing method and use
11/24/2004	CN1176651C N-(3-benzofuryl) urea derivative
11/23/2004	US6822097 Compounds and methods of uses
11/23/2004	US6822087 For anti-asthma/allergy/hypereosinophilia/inflammation/ cancer/tumor drugs; gene expression inhibition
11/23/2004	US6822075 Protein for use in the diagnosis and treatment of autoimmune, cancer and viral disorders
11/23/2004	US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants
11/23/2004	US6821984 Ring fused pyrazole derivatives as CRF antagonists
11/23/2004	US6821978 Xanthine phosphodiesterase V inhibitors
11/23/2004	US6821973 Compounds
11/23/2004	US6821966 Antiinflammatory agents
11/23/2004	US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004	US6821964 For prophylaxis and therapy of diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation
11/23/2004	US6821956 Oligodeoxynucleotide decoys for the prophylactic or therapeutic treatment of diseases associated with the binding of endogenous transcription factors to genes involved in cell growth, differentiation and signalling or to viral genes.
11/23/2004	US6821950 Antagonist of a g protein-coupled receptor, which has no agonist activity, and which has a cyclic or constrained acyclic structure
11/23/2004	US6821549 Contacting stent with a coating solution containing a coating material to be deposited on surface of stent; inserting thread through the lumen of the stent; producing relative motion between stent and thread to remove coating material
11/23/2004	CA2329788C Quinoline derivatives
11/23/2004	CA2326970C Acetylene derivatives as anti-inflammatory/analgesic agents
11/23/2004	CA2265587C Cyanidin compositions and therapeutic and diagnostic uses therefor
11/23/2004	CA2143107C Enantiomerically pure .beta.-d-dioxolane-nucleosides
11/23/2004	CA2135768C Indolocarbazole imides and the use thereof
11/23/2004	CA2131709C Immune-enhancing agent for therapeutic use in immunocompromised hosts
11/18/2004	WO2004099406A1 Method of purifying modified acarian main allergen
11/18/2004	WO2004099205A1 Azaindole compounds as kinase inhibitors
11/18/2004	WO2004099204A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors
11/18/2004	WO2004099190A1 Novel substituted benzimidazole derivatives
11/18/2004	WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/18/2004	WO2004099126A1 N-(2-PHENYLETHYL)SULFAMIDE DERIVATIVES AS INTEGRIN α4 ANTAGONISTS
11/18/2004	WO2004098639A1 METHOD OF CONTROLLING TGFβ-ORIGIN APOPTOSIS
11/18/2004	WO2004098638A1 Effector cell function inhibitor
11/18/2004	WO2004098634A2 Protein arginine n-methyltransferase 2 (prmt-2)
11/18/2004	WO2004098607A1 Pyridinyl acetonitriles
11/18/2004	WO2004073613A3 A medicine and food
11/18/2004	WO2004062686A3 Therapeutic use of modulators of notch
11/18/2004	WO2004035083A3 Compositions for the treatment of autoimmune disorders
11/18/2004	WO2004002528A9 Compositions and methods for therapeutic treatment
11/18/2004	WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents
11/18/2004	WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/18/2004	WO2002086087A3 Cytokine protein family
11/18/2004	US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases
11/18/2004	US20040230257 Enhanced bioavailability of nutrients, pharmaceutical agents, and other bioactive substances through laser resonant homogenization or modification of molecular shape or crystalline form
11/18/2004	US20040230051 Comprises nucleotide sequences coding b lymphocyte antigens for use as tool in prevention and treatment of cell proliferative disorders; immunotherapy
11/18/2004	US20040230043 Novel neurotrophic factors
11/18/2004	US20040229927 Imidazole derivatives for treatment of allergic and hyperproliferative disorders
11/18/2004	US20040229923 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
11/18/2004	US20040229897 Aid in cytokine biosynthesis
11/18/2004	US20040229896 Stable pharmaceutical compositions of desloratadine
11/18/2004	US20040229893 Substituted benzothiazole amide derivatives
11/18/2004	US20040229887 Novel imidazopyrimidinyl and imidazopyri dinyl derivatives
11/18/2004	US20040229885 Xanthine phosphodiesterase V inhibitors
11/18/2004	US20040229884 Sodium channel blockers
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229879 CRF receptor antagonists and methods relating thereto
11/18/2004	US20040229875 Administering compounds such as 4-(2-Amino-5-phenyl-pyrimidin-4-yl)-1H-pyrrole-2-carboxylic acid dimethylamide for therapy of transplant rejection, melanoma, or a cancer selected from colon, breast, lung, kidney, ovary, pancreas, CNS, or cancer of the gastric tract
11/18/2004	US20040229872 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity
11/18/2004	US20040229859 Beta-amino acid compounds as integrin antagonists
11/18/2004	US20040229852 Pharmaceutical composition for enhancing immunity, and extract of Poria
11/18/2004	US20040229851 2-Propylidene-19-nor-vitamin D compounds
11/18/2004	US20040229835 Immunostimulatory nucleic acid molecules
11/18/2004	US20040229834 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample
11/18/2004	US20040229833 Therapeutic use of cis-element decays in vivo
11/18/2004	US20040229823 For use in therapy of growth metabolic disorders
11/18/2004	US20040229795 For oncological diseases and diseases accompanying neovascularization, immune complex-mediated and autoimmune diseases, viral infections, fibrotic and granulomatous diseases, allergic diseases, degenerative diseases of the nervous system and arteriosclerosis
11/18/2004	US20040229790 Substance having an activity which modulates or inhibits proliferation of AILIM(activation inducible lymphocyte immunomodulatory molecule)-expressing cells or production of a cytokine; for treatment of rheumatoid arthritis, osteoarthritis
11/18/2004	US20040229788 Cell surface molecule mediating cell adhesion and signal transmission
11/18/2004	US20040229266 RNA interference mediating small RNA molecules
11/18/2004	US20040229260 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases
11/18/2004	US20040229212 Recombinant human mannan-binding lectin
11/18/2004	US20040228925 Stimulating anticarcinogenic immune response using injections of high molecular weight autologous urine isolates containing tumor associated antigens
11/18/2004	US20040228889 Use of N-arylmethylene ethylenediaminetriacetates, N-arylmethylene iminodiacetated or N,N'-diarylmethylene ethylenediamineacetates as doners of NO
11/18/2004	US20040228879 Streptococcus pneumoniae polysaccharide is conjugated to protein or peptide, and RSV antigen with adjuvant which is stimmulator of (cytotoxic T) lymphocytes
11/18/2004	US20040228857 administration of a human or humanized antibody expressed and glycosylated in a chinese hamster ovaries (CHO) cell expression system to treat T-cell mediated disorders, autoimmune disorders, cancer and infections; vasculitis, arthritis, lupus, psoriasis, multiple sclerosis, graft versus host disease
11/18/2004	US20040228850 comprises an enzyme (liver enzymes and mucopolysacoharidases) and an immunogen; kits; rheumatoid arthritis
11/18/2004	US20040228807 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone
11/18/2004	DE102004014929A1 Methoden und Rezepturen zur Hemmung der natürlich vorkommenden Phosphodiesterase Methods and formulations for inhibiting naturally occurring phosphodiesterase
11/18/2004	CA2524624A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors
11/18/2004	CA2524161A1 Pyridinyl acetonitriles
11/18/2004	CA2523922A1 Azaindole compounds as kinase inhibitors
11/18/2004	CA2521700A1 Piperidinyl- and piperazinyl-alkylcarbamate derivatives, preparation and therapeutic application thereof
11/17/2004	EP1477497A1 Humanized immunoglobulins and their production and use
11/17/2004	EP1477490A1 Pyrrolopyrimidine derivative
11/17/2004	EP1477489A1 Pyrrolopyrimidine derivatives
11/17/2004	EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004	EP1477482A1 Novel phenylalanine derivative
11/17/2004	EP1477478A2 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses.
11/17/2004	EP1477472A1 Substituted phenylalkanoic acid derivative and use thereof
11/17/2004	EP1477179A1 Anion exchange resin adsorbed fraction, immunopotentiator and promoter for recovery from loaded stress originating in matsutake mushroom
11/17/2004	EP1477175A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/17/2004	EP1477170A1 Antipruritics
11/17/2004	EP1477165A2 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
11/17/2004	EP1476581A2 Recombinant bovine immunodeficiency virus based gene transfer system
11/17/2004	EP1476574A2 RNA INTERFERENCE MEDIATED INHIBITION OF TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (IGF-1R) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/17/2004	EP1476545A2 Aggrecanase molecules
11/17/2004	EP1476541A2 Novel cytokine zcytor17 ligand
11/17/2004	EP1476540A1 Methods for producing gama delta t cells
11/17/2004	EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
11/17/2004	EP1476465A1 Method for producing interferon
11/17/2004	EP1476461A2 Immune-modulating peptide made of s. aureus enterotoxin b
11/17/2004	EP1476460A2 A nucleic acid encoding a g-protein-coupled receptor; and uses thereof
11/17/2004	EP1476458A2 Rna interference mediated inhibition of platelet derived growth factor (pdgf) and platelet derived growth factor receptor (pdgfr) gene expression using short interfering nucleic acid (sina)
11/17/2004	EP1476456A2 Compositions and methods for surrogate antibody modulation of an immune response and transport

1 ... 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 ... 1172